Wellington Biomedical Innovation Master Investors (Cayman) I L.P. - Insider Trading & Ownership

Entity
Company
Location
Wellington Alternative Investments Llc, 280 Congress Street, Boston, MA
Summary
The estimated value of insider holdings of Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is at least $111M dollars as of September 18, 2024. Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is the 10%+ Owner of Nuvalent, Inc. and owns shares of Nuvalent, Inc. (NUVL) stock worth about $68.3M. Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $25M. Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is the 10%+ Owner of Zenas BioPharma, Inc. and owns shares of Zenas BioPharma, Inc. (ZBIO) stock worth about $13.6M. Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is the 10%+ Owner of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $3.86M.
All Insider Reports
All Insider Reports

Ownership of Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NUVL Nuvalent, Inc. 10%+ Owner $68.3M Aug 2, 2021
VERV Verve Therapeutics, Inc. 10%+ Owner $25M Jun 21, 2021
ZBIO Zenas BioPharma, Inc. 10%+ Owner $13.6M Sep 16, 2024
ACRV Acrivon Therapeutics, Inc. 10%+ Owner $3.86M Nov 17, 2022
ARTV Artiva Biotherapeutics, Inc. 10%+ Owner Jul 22, 2024
BOLD Boundless Bio, Inc. 10%+ Owner Apr 2, 2024

Insider Transactions Reported by Wellington Biomedical Innovation Master Investors (Cayman) I L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.